Abstract
Background: Alzheimer's disease (AD) is characterized by progressive decline of
Cite
CITATION STYLE
APA
Zhang, L., Lai, Y., Lin, Y., Lee, M., Lin, S., Hsu, M., … Tempest, P. (2023). PROTAC tau degrader for the treatment of Alzheimer’s disease and primary tauopathies. Alzheimer’s & Dementia, 19(S21). https://doi.org/10.1002/alz.075453
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free